E. Skwarska et al., Randomised controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease, THORAX, 55(11), 2000, pp. 907-912
Background-A randomised trial was performed on patients presenting to hospi
tal with an exacerbation of chronic obstructive pulmonary disease (COPD) to
compare outcomes in those managed at home with support with those admitted
to hospital in the standard manner.
Methods-Over an 18 month period all patients presenting to the Royal Infirm
ary of Edinburgh on weekdays (n=718) with a diagnosis of an exacerbation of
COPD were assessed for inclusion in the trial. Patients with impaired leve
l of consciousness, acute confusion, acute changes on radiography, or an ar
terial pH of <7.35 or with other serious medical or social for admission we
re excluded. Patients randomised to home support were discharged with an ap
propriate treatment package (antibiotics, corticosteroids, nebulised bronch
odilators and, if necessary, home oxygen). They were visited by a nurse the
following day and thereafter at intervals of 2-3 days until recovery when
they were discharged from follow up. Parallel observations were made on pat
ients allocated to normal hospital admission up to the point of discharge,
Patients in both groups were assessed at home eight weeks after the initial
assessment.
Results-Among weekday patients 353 (50%) were considered obligatory admissi
ons, 140 (19%) were admitted because of co-morbidity, 17 (2%) because of po
or social circumstances, and 24 (3%) did not consent to the trial. The rema
ining 184 (26%) were randomised (2:1) either to home support or to a standa
rd hospital admission. The median time to discharge was 7 days for the home
support group and 5 days for the admitted group (p<0.01); 25% of the home
support group and 34% of the admitted group were readmitted before the fina
l assessment at eight weeks (p>0.05). There were no significant differences
between the groups in attendances by GPs and carers or in health status me
asured eight weeks after the initial assessment. Satisfaction with the serv
ice was good. The mean total health service cost per patient was estimated
as pound 877 for the home support group and pound 1753 for the admitted gro
up.
Conclusions-This study shows that home supported discharge is a well tolera
ted, safe, and economic alternative to hospital admission for a proportion
of patients referred to hospital for admission for an exacerbation of COPD.